Search

Your search keyword '"Sinisalo, Marjatta"' showing total 165 results

Search Constraints

Start Over You searched for: Author "Sinisalo, Marjatta" Remove constraint Author: "Sinisalo, Marjatta"
165 results on '"Sinisalo, Marjatta"'

Search Results

1. Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial

3. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

4. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

6. Urine sodium excretion is related to extracellular water volume but not to blood pressure in 510 normotensive and never-treated hypertensive subjects.

7. Risk of lymphoid malignancies increased after Puumala virus infection in Finland, 2009-2019: A retrospective register-based cohort study

8. Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial

9. Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

10. Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group

12. Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

13. Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial.

14. Risk of venous thromboembolism in COVID‐19 infection.

21. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

23. Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013

24. Real-world treatment outcomes in multiple myeloma : Multicenter registry results from Finland 2009-2013

26. Kohtauksittainen yöllinen hemoglobiinivirtsaisuus (PNH)

30. Early MRD-Negativity May Predict for Favorable Outcome Irrespective of Allotransplantation in TKI-Treated Patients with Ph-Positive Acute Lymphoblastic Leukemia

31. High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation

36. Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol – a prospective nationwide study.

37. Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

38. Combination of pegylated IFN-alpha 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

39. Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-alpha Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile

40. A Randomized Phase II Study Comparing Imatinib and the Combination of Imatinib and Pegylated Interferon Alpha-2b in Newly Diagnosed Non-High Risk Chronic Myeloid Leukemia (CML) Patients in Complete Hematological Remission After Imatinib Induction Therapy. in BLOOD, vol 114, issue 22, pp 1269-1270

41. Invasive pneumococcal disease in patients with haematological malignancies before routine use of conjugate vaccines in Finland.

43. Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile

45. Interferon Alpha Treated Patients with Chronic Myeloid Leukemia (CML) In Prolonged Complete Remission Have Increased Numbers of NK-Cells and Clonal Gamma-Delta T-Cells, and a Distinct Plasma Cytokine Profile.

47. Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy

49. Clonal Large Granular Lymphocyte (LGL) Expansion Associated with Dasatinib Therapy.

50. Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant.

Catalog

Books, media, physical & digital resources